ETFs
U
UTHR
United Therapeutics Corp.
497.59
+4.49+0.91%After Hours: 497.59 0.00 0.00%16:50 09/22 EDT
OPEN/PREV CLOSE493.98/493.10
TODAY RANGE488.08-499.58
VOL392.86K
MARKET CAP21.34B
52 WEEK RANGE409.07-609.35
AVG VOL (3M)562.18K
% TURNOVER0.65%
TURNOVER--
P/E (TTM)17.80
% RANGE2.33%
EPS(TTM)27.96
P/E(FORWARD)19.11
P/B3.318
BVPS149.97
DIVIDEND--
P/S6.82
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP20.90B
SHARES OUTSTANDING42.89M
NEXT EARNINGS10/27-11/02
FREE FLOAT41.99M
LOT SIZE1
EX-DATE09/23/2009
News
Press Releases
Financial Reports
Profile
NASDAQ·1d ago
SPMD, THC, UTHR, XPO: ETF Inflow Alert
Simply Wall St·5d ago
United Therapeutics (UTHR) Pullback Keeps Its Pipeline Led Valuation Story In Focus
Simply Wall St·09/14 11:29
Does FDA Filing Acceptance Change The Bull Case For United Therapeutics Stock?
Simply Wall St·09/12 07:22
Is United Therapeutics (UTHR) Still A Bargain, Or Largely Priced In?
TipRanks·09/12 00:25
These 3 ETFs Could Deliver Over 12% Upside, According to the AI Analyst
Simply Wall St·09/10 08:19
Is United Therapeutics (UTHR) A Bargain Following Its Tyvaso FDA Acceptance?
TipRanks·09/08 21:28
United Therapeutics Announces New Accelerated Share Repurchase
Seeking Alpha·09/08 11:50
United Therapeutics enters $477.6M accelerated share repurchase
TipRanks·09/08 11:05
United Therapeutics announces accelerated share repurchase agreement
Simply Wall St·09/05 00:28
United Therapeutics (UTHR) Stock May Be Undervalued Despite Its 132% Run
NASDAQ·09/03 15:43
FDA Accepts UTHR's sNDA for Tyvaso in Idiopathic Pulmonary Fibrosis
Benzinga·09/03 10:09
Top 3 Health Care Stocks Which Could Rescue Your Portfolio In Q3
TipRanks·09/02 15:05
Wells Fargo Reaffirms Their Buy Rating on United Therapeutics (UTHR)
Same Industry
Name/Symbol
Change%
Price